Gu, X., Shi, Z., Shao, L., Zhang, Y., Zhang, Y., Song, Z., . . . Lou, G. (2022). Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer. BMC Cancer, 22(1), 1. https://doi.org/10.1186/s12885-022-09674-2
Chicago-referens (17:e uppl.)Gu, Xiaodong, Zhiyong Shi, Lan Shao, Yuxin Zhang, Yiping Zhang, Zhengbo Song, Wenxian Wang, och Guangyuan Lou. "Efficacy and Safety of Maintenance Immune Checkpoint Inhibitors with or Without Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer." BMC Cancer 22, no. 1 (2022): 1. https://doi.org/10.1186/s12885-022-09674-2.
MLA-referens (9:e uppl.)Gu, Xiaodong, et al. "Efficacy and Safety of Maintenance Immune Checkpoint Inhibitors with or Without Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer." BMC Cancer, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12885-022-09674-2.
